Discovery and Synthesis of Novel Beesioside I Derivatives with Potent Anti-Hiv Activity.
Haifeng Wu,Guoxu Ma,Qinwen Yang,Yindi Zhu,Li Huang,Yu Tian,Xiaoming Yang,Menghan Zhang,Chin-Ho Chen,Susan L. Morris-Natschke,Meihua Yang,Xudong Xu,Kuo-Hsiung Lee
DOI: https://doi.org/10.1016/j.ejmech.2019.01.020
IF: 7.088
2019-01-01
European Journal of Medicinal Chemistry
Abstract:In this study, 12 known cycloartane triterpenoids (1-12) with four different skeletons isolated from the roots of Souliea vaginata were screened for the first time for in vitro anti-HIV activity using AZT as a standard. Among the compounds, beesioside 1 (1) showed the highest potency against HIV-1(NL4-3) with an EC50 value of 2.32 mu M (CC50 > 40 mu M). Preliminary structure-activity relationship (SAR) studies on 1 indicated that simple modification of its aglycone (13) could significantly influence the antiviral activity. Particularly, the introduction of an acyl group at the C-3 position of 13 led to significant improvement in both anti-HIV potency and selectivity index. Among all synthetically modified derivatives, compound 13g was the most potent compound with an EC50 value of 0.025 mu M and TI value greater than 800, comparable to those of 3-O-(3',3'-dimethylsuccinyl)-betulinic acid (DSB, bevirimat). Other analogues exhibited strong to weak inhibition of HIV-1 replication in MT-4 cells. The length, carboxylic terminus, and C-3' dimethyl substitution of the C-3 side chain substantially affected the anti-HIV activity. Finally, compound 13g was an effective agent against HIV with high potential for further investigation. (C) 2019 Elsevier Masson SAS. All rights reserved.